Association of glucagon-like peptide-1 receptor-targeted imaging probe with in vivo glucagon-like peptide-1 receptor agonist glucose-lowering effects.
Takaaki MurakamiHiroyuki FujimotoNaotaka FujitaKeita HamamatsuDaisuke YabeNobuya InagakiPublished in: Journal of diabetes investigation (2020)
Ex vivo 111 In-Ex4 pancreatic values reflected dulaglutide efficacy, suggesting clinical possibilities for expanding GLP-1R-targeted imaging applications.